奥氮平治疗老年痴呆伴发精神行为障碍临床分析.docxVIP

奥氮平治疗老年痴呆伴发精神行为障碍临床分析.docx

  1. 1、原创力文档(book118)网站文档一经付费(服务费),不意味着购买了该文档的版权,仅供个人/单位学习、研究之用,不得用于商业用途,未经授权,严禁复制、发行、汇编、翻译或者网络传播等,侵权必究。。
  2. 2、本站所有内容均由合作方或网友上传,本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺!文档内容仅供研究参考,付费前请自行鉴别。如您付费,意味着您自己接受本站规则且自行承担风险,本站不退款、不进行额外附加服务;查看《如何避免下载的几个坑》。如果您已付费下载过本站文档,您可以点击 这里二次下载
  3. 3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等,请点击“版权申诉”(推荐),也可以打举报电话:400-050-0827(电话支持时间:9:00-18:30)。
  4. 4、该文档为VIP文档,如果想要下载,成为VIP会员后,下载免费。
  5. 5、成为VIP后,下载本文档将扣除1次下载权益。下载后,不支持退款、换文档。如有疑问请联系我们
  6. 6、成为VIP后,您将拥有八大权益,权益包括:VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
  7. 7、VIP文档为合作方或网友上传,每下载1次, 网站将根据用户上传文档的质量评分、类型等,对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档
查看更多
奥氮平治疗老年痴呆伴发精神行为障碍临床分析

奥氮平治疗老年痴呆伴发精神行为障碍临床分析   [摘要] 目的 分析和研究奥氮平治疗老年痴呆伴发精神行为障碍的临床疗效。方法 方便该院在XX年5月―XX年5月期间收治的136例老年痴呆伴发精神行为障碍的患者作为研究对象,按照患者入院单号单双将其分为参照组和研究组,各68例,其中参照组患者采用利培酮治疗,研究组患者采用奥氮平治疗,观察和比较两组患者的临床疗效、不良反应发生情况以及阿尔兹海默病病理评分。结果 参照组患者的治疗总有效率和不良反应发生率分别为%、%,研究组患者的治疗总有效率和不良反??发生率分别为%、%,由此可见,研究组患者治疗有效率略高于参照组,差异无统计学意义;研究组患者的不良反应发生率要显著低于参照组,且研究组患者的阿尔兹海默病病理行为也得到明显改善,差异有统计学意义。 结论 采用奥氮平治疗老年痴呆伴发精神行为障碍,患者的临床症状能够得到有效改善,且安全性更高,在临床中值得推广。   [关键词] 老年痴呆;伴发精神行为障碍;利培酮;奥氮平;临床疗效   [中图分类号] R5 [文献标识码] A [文章编号] 1674--0007-03   The Clinical Analysis of Olanzapine in the Treatment of Senile Dementia with Psychiatric Behavior Disorder   YI Shuai, YU Xiao-feng   Department of Neurology, Qingdao People’s Hospital, Qingdao, Shandong Province, China   [Abstract] Objective This paper tries to analyze and study the clinical efficacy of olanzapine in the treatment of dementia with senile dementia. Methods 136 cases of senile dementia patients with comorbid mental behavior disorder from May XX to May XX were convenient selected as the research objects, according to the patients admission order, single and double number, they were divided into control group and the study group, with 68 cases in each group, the control group was treated by risperidone treatment, treatment group was treated by olanzapine, to observe and compare the clinical efficacy of two groups of patients, adverse reactions, and alzheimers disease pathology score. Results The treatment of patients with the control group of the total effective rate and the incidence of adverse reactions were %, %, and those of the study group of total effective rate and the incidence of adverse reactions were % and % respectively, thus, the stuey group was slightly higher than that of control group without statistically significant difference; the incidence of adverse reactions was significantly lower than that of control group, and the alzheimers disease pathological behavior had also been improved significantly, the difference was statistically significant. Conclusion T

文档评论(0)

dajia1qi + 关注
实名认证
文档贡献者

该用户很懒,什么也没介绍

1亿VIP精品文档

相关文档